Myriad Genetics: From Concept to Reality
|Lessons learned in bringing a life sciences company from concept to reality. A discussion of Myriad's more notable, innovative deals, and how those deals were structured to bring lifesaving technologies from lab to market. The recent Supreme Court case addressing the patentability of genetic material will also be discussed. This decision will have substantial implications not just for the life sciences industry, but for commercialization of all inventions from natural products to software. |
"No other event brings together the high level and broad mix of intellectual property, business development and licensing professionals like the LES Annual Meeting does."
- Stasia Ogden, Associate General Counsel and Chief IP Counsel, Baxter Healthcare Corporation